Aurinia Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Aurinia Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Aurinia Pharmaceuticals Inc Strategy Report
- Understand Aurinia Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Aurinia Pharmaceuticals Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Aurinia Pharmaceuticals Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 14 Oct 2020 | Lorem |
| Aurinia’s voclosporin may report positive Phase II/III data but dry eye superiority prospects to Allergan’s Restasis, clinical relevance remains nebulous, experts say | 29 Jul 2020 | Bernarda Tundzhay |
| Aurinia’s voclosporin use likely to be relegated to later lines after exhausting generic SOC; steroid-sparing ability attractive but not gamechanger, experts say | 30 Jul 2019 | Manasi Vaidya,Shuan Sim |
| Aurinia’s voclosporin still has potential Phase III lupus nephritis mortality risk despite mitigation strategies, experts say | 26 Jul 2019 | Manasi Vaidya,Shuan Sim |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer